Sleep-Wake Disorders

18 soru

Soru 1Soru →

Match each clinical presentation to the most accurate sleep-wake disorder diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Narcolepsy Type 1
REM Sleep Behavior Disorder
Non-REM Sleep Arousal Disorder
Delayed Sleep-Wake Phase Disorder

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Narcolepsy Type 1 matches with the young woman experiencing cataplexy; REM Sleep Behavior Disorder matches with the older man enacting vivid dreams; Non-REM Sleep Arousal Disorder matches with the young child having sleep terrors with amnesia; and Delayed Sleep-Wake Phase Disorder matches with the college student exhibiting a shifted sleep schedule.
Each clinical vignette provides pathognomonic features for specific sleep-wake disorders. Narcolepsy type 1 is defined by cataplexy and sleepiness. REM sleep behavior disorder is characterized by dream enactment due to absent REM atonia. Non-REM sleep arousal disorder (sleep terrors) presents with profound autonomic arousal and amnesia for the episode. Delayed sleep-wake phase disorder involves a shifted but otherwise normal circadian sleep pattern.

Adım Adım Çözüm

1
Analyze the young woman's presentation.
She presents with chronic sleepiness and emotion-triggered muscle weakness.
These are the classic signs of hypersomnolence and cataplexy, pointing directly to Narcolepsy Type 1.
2
Evaluate the older man's nocturnal behaviors.
He exhibits physical actions during sleep and vividly remembers dreaming.
This indicates a failure of the normal muscle paralysis (atonia) that should occur during REM sleep, diagnosing REM Sleep Behavior Disorder.
3
Assess the pediatric patient's nighttime awakenings.
The child wakes up terrified, cannot be consoled, and does not remember the event.
These features distinguish Non-REM sleep terrors (occurring in slow-wave sleep without dream recall) from typical nightmares.
4
Review the college student's sleep schedule.
The patient has a severely delayed sleep onset but normal sleep duration when allowed to sleep in.
This pattern is a circadian rhythm misalignment known as Delayed Sleep-Wake Phase Disorder.

Anahtar Kavram

Clinical differentiation of major sleep-wake disorders based on symptomatology, sleep cycle stage, and patient demographics.
Soru 2Soru →

A 68-year-old retired mechanic is brought to the clinic by his wife due to excessive daytime sleepiness and frequent nighttime awakenings over the past two months. His wife reports that he sleeps restlessly and has episodes where he completely stops breathing for about 20 seconds at a time. The patient has a history of a myocardial infarction four years ago, type 2 diabetes mellitus, and hypertension. His current medications include metformin, low-dose aspirin, and amlodipine. Vital signs are temperature 37.0°C (98.6°F), blood pressure 118/76 mmHg, heart rate 92/min, and respiratory rate 18/min. BMI is 26 kg/m226 \text{ kg/m}^2. Physical examination reveals a laterally displaced point of maximal impulse, a faint third heart sound (S3), and trace bilateral lower extremity pitting edema. A polysomnography study demonstrates recurrent episodes of apnea without associated chest or abdominal wall movement, occurring between periods of a crescendo-decrescendo breathing pattern. Which of the following is the most appropriate initial step in the management of this patient's sleep disorder?

Cevabı ve açıklamayı göster

Cevap: Initiate furosemide and lisinopril therapy

Cevap

Initiate furosemide and lisinopril therapy
The correct answer identifies the need to treat the underlying cause of the patient's sleep disorder. The patient's polysomnography demonstrates central sleep apnea (apnea without respiratory effort) characterized by a crescendo-decrescendo tidal volume pattern. This is the hallmark of Cheyne-Stokes respiration, a condition driven by delayed circulation times and abnormal feedback loops in the respiratory control center, most commonly due to congestive heart failure. The physical exam confirms fluid overload and left ventricular dilation (displaced apical impulse, S3). For central sleep apnea caused by heart failure, the primary and initial intervention is to aggressively optimize the medical regimen for heart failure (e.g., initiating a loop diuretic like furosemide and an ACE inhibitor like lisinopril).

Adım Adım Çözüm

1
Interpret the polysomnography findings.
The study shows apneic episodes without chest or abdominal wall movement (lack of respiratory effort) interspersed with a crescendo-decrescendo breathing pattern.
This specific pattern defines Cheyne-Stokes respiration and central sleep apnea, differentiating it from obstructive sleep apnea where respiratory effort is maintained.
2
Correlate the sleep study pattern with the physical examination.
The patient has a laterally displaced point of maximal impulse, an S3 gallop, and peripheral edema.
These findings indicate decompensated congestive heart failure, which is the classic underlying cause of Cheyne-Stokes respiration.
3
Determine the most appropriate initial management.
The first-line intervention is to optimize the medical management of heart failure (e.g., using diuretics, ACE inhibitors, and beta-blockers).
Treating the underlying hemodynamic derangement in congestive heart failure often improves or resolves the associated central sleep apnea before specific airway interventions are required.

Anahtar Kavram

Central sleep apnea with Cheyne-Stokes respiration is heavily associated with advanced heart failure. The initial treatment is optimization of guideline-directed medical therapy for heart failure.
Soru 3Soru →

A 38-year-old woman comes to the clinic reporting persistent daytime fatigue and sleepiness for the past 14 months. She works as a software engineer and frequently dozes off at her desk during the mid-afternoon, occasionally making embarrassing errors in her code. She goes to bed at 10:30 PM and wakes up at 6:30 AM daily, feeling relatively refreshed initially, but severe sleepiness returns by midday. She reports that occasionally, right before drifting off to sleep at night, she hears unfamiliar voices calling her name in the room, though she lives alone. She has no episodes of sudden muscle weakness when laughing or angry. Her medical history is unremarkable, and she takes no medications. Physical examination is within normal limits. An overnight polysomnogram (PSG) reveals a total sleep time of 7.9 hours, an apnea-hypopnea index of 1.5 events/hour, and a rapid eye movement (REM) sleep latency of 10 minutes. The next day, a multiple sleep latency test (MSLT) demonstrates a mean sleep latency of 5.5 minutes and 1 sleep-onset REM period (SOREMP). Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Prescribe modafinil

Cevap

The correct answer is to prescribe modafinil.
The correct answer is prescribing modafinil. This patient presents with severe excessive daytime sleepiness and hypnagogic hallucinations (hearing voices when falling asleep), which are classic symptoms of narcolepsy. The definitive diagnosis of narcolepsy requires objective testing with a multiple sleep latency test (MSLT). The criteria mandate a mean sleep latency of ≤ 8 minutes and the presence of ≥ 2 sleep-onset REM periods (SOREMPs). While this patient's MSLT only demonstrated 1 SOREMP, she had a REM latency of 10 minutes on the preceding night's polysomnogram (PSG). According to standardized diagnostic criteria, a REM latency of ≤ 15 minutes on the preceding night's PSG counts as one of the required SOREMPs. Therefore, combining the 1 SOREMP from the PSG and the 1 SOREMP from the MSLT satisfies the requirement of ≥ 2 SOREMPs. Because she lacks cataplexy, she has narcolepsy type 2. Modafinil, a wakefulness-promoting agent, is a first-line pharmacotherapy for managing daytime sleepiness in narcolepsy.

Adım Adım Çözüm

1
Identify the patient's primary symptoms and behavioral history.
Excessive daytime sleepiness for over 3 months despite adequate (8 hours) sleep, accompanied by hypnagogic hallucinations (hearing voices while falling asleep), raising high clinical suspicion for narcolepsy.
Establishing the clinical presentation is the first step in directing the interpretation of the objective sleep studies.
2
Evaluate the overnight polysomnogram (PSG) findings.
The apnea-hypopnea index (AHI) is 1.5 events/hour (normal is < 5), ruling out obstructive sleep apnea. The REM sleep latency is abnormally short at 10 minutes.
PSG is required to rule out other causes of hypersomnolence (like OSA) and provides crucial baseline sleep architecture data.
3
Apply the diagnostic criteria rule regarding REM latency on the PSG.
A REM sleep latency of 15 minutes or less on the preceding night's PSG qualifies as one sleep-onset REM period (SOREMP).
This is a critical, advanced nuance in the diagnostic criteria for narcolepsy that prevents false-negative interpretations of the MSLT.
4
Evaluate the multiple sleep latency test (MSLT) findings.
The mean sleep latency is severely reduced at 5.5 minutes (pathological is ≤ 8 minutes), and 1 SOREMP is observed during the daytime naps.
The MSLT provides the objective measure of daytime sleepiness and propensity to enter REM sleep quickly.
5
Synthesize the total SOREMP count and confirm the diagnosis.
1 SOREMP (from PSG) + 1 SOREMP (from MSLT) = 2 total SOREMPs. Combined with the mean sleep latency ≤ 8 minutes and absence of cataplexy, this confirms Narcolepsy Type 2.
Accurate diagnosis dictates the appropriate pharmacological intervention.
6
Determine the most appropriate first-line management.
Modafinil is selected to manage the patient's debilitating daytime sleepiness.
Modafinil, a non-amphetamine wakefulness-promoting agent, is standard first-line therapy for narcolepsy.

Anahtar Kavram

The diagnosis of narcolepsy requires an MSLT showing a mean sleep latency ≤ 8 minutes and ≥ 2 SOREMPs; crucially, a REM latency ≤ 15 minutes on the preceding night's PSG counts as one of the required SOREMPs.
Soru 4Soru →

A 20-year-old man presents to the university health clinic complaining of excessive daytime sleepiness that has progressively worsened over the past 8 months. He reports struggling to stay awake during lectures and has fallen asleep several times while eating meals. The patient also describes episodes where he suddenly loses muscle tone in his knees when he hears a funny joke, causing him to occasionally fall to the floor. He remains fully awake and aware of his surroundings during these brief events. Additionally, he mentions seeing vivid, frightening shadows in his room just before he falls asleep at night. He has no past medical history, does not use illicit drugs, and takes no medications. Vital signs and physical examination are unremarkable. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Narcolepsy

Cevap

The most likely diagnosis is narcolepsy.
The correct diagnosis is narcolepsy. This patient presents with excessive daytime sleepiness, cataplexy (sudden loss of muscle tone triggered by laughter), and hypnagogic hallucinations (vivid visual imagery occurring while falling asleep). These features form the classic clinical presentation of narcolepsy type 1, which is fundamentally caused by a deficiency of orexin (hypocretin) in the lateral hypothalamus.

Adım Adım Çözüm

1
Analyze the patient's primary complaint.
The patient has experienced severe excessive daytime sleepiness for 8 months.
To establish the core symptom of the sleep-wake disorder.
2
Identify specific associated symptoms triggered by emotion or sleep transition.
The patient experiences sudden loss of muscle tone with laughter (cataplexy) and visual hallucinations upon falling asleep (hypnagogic hallucinations).
To differentiate the condition from other causes of hypersomnia, such as depression or drug interactions.
3
Synthesize the clinical findings to formulate a diagnosis.
The combination of excessive daytime sleepiness, cataplexy, and hypnagogic hallucinations is the classic triad for narcolepsy.
To select the correct diagnosis among the provided choices.

Anahtar Kavram

Narcolepsy type 1 is a sleep-wake disorder classically characterized by excessive daytime sleepiness, cataplexy (sudden loss of muscle tone triggered by strong emotions), hypnagogic/hypnopompic hallucinations, and sleep paralysis.
Soru 5Soru →

Match each clinical presentation with the most likely sleep-wake disorder diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old obese man presents with loud snoring, witnessed gasping during sleep, and morning headaches.
A 22-year-old woman experiences overwhelming daytime sleepiness and sudden bilateral muscle weakness triggered by laughing.
A 45-year-old woman complains of a 'crawling' sensation in her legs occurring only when lying in bed, which improves with walking.
A 68-year-old man frequently punches and kicks his partner during sleep while 'fighting off attackers' in his vivid dreams.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Obstructive Sleep Apnea matches with the snoring and obese patient. Narcolepsy Type 1 matches with the sleepiness and cataplexy presentation. Restless Legs Syndrome matches with the leg crawling sensation. REM Sleep Behavior Disorder matches with the dream enactment.
Each presentation matches a distinct sleep disorder mechanism: anatomical airway obstruction causes Obstructive Sleep Apnea; hypocretin deficiency causes the cataplexy seen in Narcolepsy Type 1; dopaminergic dysfunction is thought to drive the sensory urges in Restless Legs Syndrome; and brainstem pathway degeneration leads to the loss of atonia in REM Sleep Behavior Disorder.

Adım Adım Çözüm

1
Analyze the first clinical vignette regarding the 55-year-old obese man.
The symptoms of loud snoring, witnessed gasping, and morning headaches indicate upper airway collapse during sleep.
This constellation of symptoms perfectly matches Obstructive Sleep Apnea.
2
Analyze the second clinical vignette regarding the 22-year-old woman.
The presence of overwhelming daytime sleepiness alongside sudden muscle weakness triggered by laughter (cataplexy) is identified.
Cataplexy is highly specific for Narcolepsy Type 1.
3
Analyze the third clinical vignette regarding the 45-year-old woman.
The 'crawling' sensation in the legs that occurs at rest and is relieved by movement is recognized.
These are the diagnostic clinical criteria for Restless Legs Syndrome.
4
Analyze the fourth clinical vignette regarding the 68-year-old man.
The act of physically fighting during vivid dreams indicates a failure of the normal motor paralysis that should occur during REM sleep.
This lack of REM atonia with dream enactment defines REM Sleep Behavior Disorder.

Anahtar Kavram

Clinical presentation and diagnostic criteria of primary sleep-wake disorders.
Soru 6Soru →

A 45-year-old woman presents to the clinic with a 6-month history of difficulty falling asleep and staying asleep. She states that her sleep problems began after a stressful period at work but have persisted despite the stress resolving. She reports daytime fatigue that is noticeably affecting her job performance. She has no other medical conditions and takes no medications. Arrange the following steps in the most appropriate chronological sequence for the standard clinical management of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing chronic insomnia is to first assess sleep patterns objectively using a sleep diary, then initiate Cognitive Behavioral Therapy for Insomnia (CBT-I) as first-line treatment, consider short-term nonbenzodiazepine hypnotics only if CBT-I is ineffective, and finally taper any medications to avoid physical dependence and rebound symptoms.
The standard stepwise approach to chronic insomnia begins with a thorough clinical assessment using a sleep diary. This is followed by the first-line treatment, Cognitive Behavioral Therapy for Insomnia (CBT-I). Pharmacotherapy (such as nonbenzodiazepine hypnotics, dual orexin receptor antagonists, or melatonin agonists) is reserved for cases refractory to CBT-I and should only be used short-term. When discontinuing these medications, they must be gradually tapered to prevent rebound insomnia.

Adım Adım Çözüm

1
Identify the patient's likely diagnosis based on the clinical vignette.
The patient has chronic insomnia disorder (symptoms > 3 months, causing daytime impairment, not explained by other conditions).
Establishing the correct diagnosis dictates the appropriate stepwise treatment algorithm.
2
Determine the initial assessment and diagnostic steps.
A sleep diary is the standard initial tool to quantify sleep latency, wake after sleep onset, and total sleep time.
Objective tracking is necessary to guide behavioral therapy and measure clinical progress.
3
Identify the recommended first-line therapy.
Cognitive Behavioral Therapy for Insomnia (CBT-I) is selected as the primary intervention.
Guidelines recommend CBT-I as the initial treatment due to its sustained efficacy and lack of side effects compared to medications.
4
Determine the role of pharmacotherapy.
Medications (like nonbenzodiazepine hypnotics) are reserved for patients who do not respond adequately to CBT-I.
Sleep medications carry risks of dependence, tolerance, and adverse effects, especially with prolonged use.
5
Identify the protocol for discontinuing pharmacotherapy.
Medications must be carefully tapered rather than stopped abruptly.
Abrupt cessation of hypnotics typically causes severe rebound insomnia, which can perpetuate the cycle of sleep anxiety and medication reliance.

Anahtar Kavram

The standard clinical management of chronic insomnia emphasizes objective assessment followed by targeted behavioral interventions (CBT-I) before considering short-term pharmacological therapies.
Tahmini Süre:1m 0s
Soru 7Soru →

Evaluated in the sleep clinic is a young adult university student reporting a two-year history of debilitating daytime hypersomnolence. The patient frequently falls asleep during interactive seminars despite maintaining a self-reported 8-hour nightly sleep schedule. In addition, the patient describes recent episodes where hearing a funny joke causes transient buckling of the knees and jaw drooping, with preserved consciousness throughout the event. Suspecting a specific central disorder of hypersomnolence, the clinician plans a comprehensive evaluation and treatment strategy. Arrange the following diagnostic and therapeutic steps in the most appropriate, guideline-directed chronological sequence for the management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Actigraphy and sleep diary, 2) Nocturnal polysomnography, 3) Multiple sleep latency test, 4) Initiation of a wake-promoting agent, 5) Addition of a REM-suppressing medication.
The correct diagnostic and therapeutic pipeline for Narcolepsy Type 1 (narcolepsy with cataplexy) mandates a strict sequence to prevent misdiagnosis. First, actigraphy rules out insufficient sleep. Second, NPSG rules out alternative pathologies (e.g., OSA) and validates the subsequent test. Third, the MSLT confirms the specific hypersomnia phenotype. Only after objective confirmation should lifelong pharmacotherapy be initiated, starting with wake-promoting agents for somnolence, followed by REM-suppressants (SNRIs) or sodium oxybate for cataplexy.

Adım Adım Çözüm

1
Rule out behavioral causes of hypersomnolence
Use wrist actigraphy for 1-2 weeks to verify adequate total sleep time.
Chronic insufficient sleep is the most common cause of daytime sleepiness and can cause false-positive MSLT findings.
2
Rule out structural/physiologic nocturnal sleep disorders
Perform an overnight NPSG.
Conditions like obstructive sleep apnea or periodic limb movement disorder must be excluded. Furthermore, a minimum of 6 hours of sleep on NPSG is required to validate the next day's MSLT.
3
Confirm the diagnosis of Narcolepsy Type 1
Conduct an MSLT the day immediately following the NPSG.
Demonstrating rapid sleep onset (≤ 8 mins) and early REM transition (≥ 2 SOREMPs) objectively confirms the clinical suspicion of narcolepsy.
4
Treat excessive daytime sleepiness
Prescribe modafinil, armodafinil, or pitolisant.
These are first-line treatments to maintain wakefulness and improve functional capacity during the day.
5
Treat cataplexy
Prescribe an SNRI, SSRI, or sodium oxybate.
Cataplexy (the buckling of knees/jaw drooping described in the stem) is managed specifically with REM-suppressing agents once the diagnosis is confirmed.

Anahtar Kavram

The diagnostic algorithm for Narcolepsy Type 1 requires objective documentation of sufficient pre-test sleep (actigraphy), exclusion of other sleep disorders (NPSG), and confirmation of hypersomnolence with REM intrusion (MSLT) prior to pharmacotherapy.
Soru 8Soru →

A 42-year-old high school teacher presents for evaluation of a 7-month history of difficulty initiating sleep and frequent, prolonged nocturnal awakenings. The patient reports spending over 9 hours in bed each night in a desperate attempt to feel rested, but estimates achieving only 4 to 5 hours of total sleep. The resulting severe daytime fatigue has begun to impair her teaching performance and daily functioning. She denies snoring, witnessed apneic events, or an urge to move her legs at rest. Physical examination, neurologic assessment, and routine laboratory studies are unremarkable.

Arrange the following clinical interventions in the most appropriate chronological sequence for the evidence-based, stepped-care management of this patient's condition, proceeding from initial assessment to subsequent escalations for refractory symptoms.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The chronological management of chronic insomnia begins with a sleep diary to establish baseline sleep efficiency, followed by Cognitive Behavioral Therapy for Insomnia (CBT-I) as the primary definitive treatment. If CBT-I is ineffective, a trial of a primary pharmacologic agent is initiated. If that initial agent fails, the patient should transition to a different medication class or undergo comprehensive reassessment for occult comorbidities.
The optimal management of chronic insomnia follows a strict evidence-based, stepped-care approach. First, a sleep diary is utilized to objectively document sleep patterns, calculate baseline sleep efficiency, and identify targets for behavioral modification. Second, Cognitive Behavioral Therapy for Insomnia (CBT-I) is initiated as the first-line definitive treatment, utilizing techniques like sleep restriction to consolidate the patient's highly fragmented sleep. Third, if CBT-I is insufficient, a trial of an FDA-approved pharmacologic agent is indicated. Finally, if the patient does not respond to the initial medication, the appropriate next step is to transition to a medication from a different pharmacologic class or perform a comprehensive reassessment for underlying occult conditions.

Adım Adım Çözüm

1
Establish a clinical baseline and identify maladaptive behaviors.
Instruct the patient to keep a 1-to-2 week sleep diary.
To accurately calculate baseline sleep efficiency and document the exact discrepancy between time in bed and total sleep time, which is required to tailor behavioral interventions.
2
Initiate first-line definitive non-pharmacologic therapy.
Implement Cognitive Behavioral Therapy for Insomnia (CBT-I).
Current guidelines mandate CBT-I (including stimulus control and sleep restriction) as the first-line treatment for chronic insomnia disorder due to its sustained efficacy and lack of adverse drug effects.
3
Escalate to pharmacotherapy for refractory symptoms.
Trial an FDA-approved insomnia medication (e.g., suvorexant, zolpidem).
Medications are indicated strictly as a second-line intervention when CBT-I alone does not achieve clinical remission or is completely inaccessible to the patient.
4
Manage primary pharmacotherapy failure.
Switch to an alternative medication class or perform a psychiatric reassessment.
Refractory insomnia requires targeting a different neurochemical pathway (e.g., histamine via doxepin) and re-evaluating to ensure secondary causes of insomnia are not being missed.

Anahtar Kavram

Stepped-care diagnostic and management pathway for Chronic Insomnia Disorder

Alternatif Yöntem

While CBT-I is the gold standard, in clinical settings where certified CBT-I providers are completely unavailable, primary care physicians may utilize abbreviated behavioral interventions (Brief Behavioral Treatment for Insomnia - BBTI) alongside digital CBT-I applications as an alternative bridging step before resorting to pharmacotherapy.
Tahmini Süre:2m 0s
Soru 9Soru →

A 52-year-old woman comes to the primary care clinic for evaluation of sleep disturbance and leg discomfort over the past 3 months. She describes a deep, "crawling" sensation in her calves and thighs that begins almost exclusively when she lies down in bed or relaxes on the couch in the evening. The sensation is accompanied by an irresistible urge to move her legs, and she must pace the hallway for several minutes to find temporary relief. She has no symptoms during the day and sits calmly throughout the examination. Her medical history is significant for bipolar I disorder, hyperlipidemia, and uterine leiomyomas causing heavy menstrual bleeding. Current medications include lithium, lurasidone, and atorvastatin. Vital signs are normal. Neurological examination shows no resting tremor, rigidity, or focal deficits. Laboratory testing reveals a hemoglobin of 11.2 g/dL11.2 \text{ g/dL}, mean corpuscular volume of 76 fL76 \text{ fL}, and serum ferritin of 18 ng/mL18 \text{ ng/mL} (Normal: 15−200 ng/mL15-200 \text{ ng/mL}). Which of the following is the most appropriate next step in the management of this patient's sleep-related symptoms?

Cevabı ve açıklamayı göster

Cevap: Oral ferrous sulfate

Cevap

Oral ferrous sulfate
The correct answer is oral ferrous sulfate. This patient's clinical presentation meets the four core diagnostic criteria for Restless Legs Syndrome (RLS): an urge to move the legs, worsening of symptoms during periods of rest or inactivity, partial or total relief with movement, and worsening of symptoms in the evening or night. RLS can be primary (idiopathic) or secondary to other conditions, with iron deficiency being one of the most common and reversible secondary causes. This patient's history of heavy menstrual bleeding and her laboratory results (microcytic anemia with a serum ferritin of 18 ng/mL18 \text{ ng/mL}) confirm iron deficiency. Current clinical guidelines state that for patients with RLS and a fasting serum ferritin level below 75 ng/mL75 \text{ ng/mL}, oral iron supplementation is the most appropriate first-line treatment. Symptomatic pharmacotherapy is generally reserved for patients with normal iron stores or those whose symptoms persist after adequate iron replacement.

Adım Adım Çözüm

1
Analyze the clinical presentation to identify the primary syndrome.
The patient describes an urge to move the legs, worsening at rest, relief with movement, and evening predominance, which fulfills the diagnostic criteria for Restless Legs Syndrome (RLS).
Accurate diagnosis relies on recognizing the four core clinical features of RLS (the URGE criteria).
2
Differentiate the symptoms from medication-induced side effects.
The lack of daytime restlessness and the prominent circadian pattern distinguish her symptoms from akathisia, an adverse effect of her lurasidone therapy.
Antipsychotic-induced akathisia typically presents as a constant, non-circadian inner restlessness, which requires a different management strategy.
3
Identify secondary causes of the diagnosed syndrome.
The laboratory findings of microcytic anemia and low serum ferritin (18 ng/mL18 \text{ ng/mL}) indicate iron deficiency, a major reversible cause of RLS.
Current guidelines recommend evaluating iron stores in all patients presenting with RLS symptoms.
4
Select the most appropriate initial therapy based on the underlying etiology.
Oral iron supplementation is the indicated next step in management.
For patients with RLS and a serum ferritin level below 75 ng/mL75 \text{ ng/mL}, replenishing iron stores is the first-line treatment before initiating symptomatic pharmacotherapy.

Anahtar Kavram

Restless Legs Syndrome (RLS) is clinically diagnosed by an urge to move the legs that worsens at rest and in the evening, and improves with movement. First-line management involves checking a serum ferritin level and prescribing iron supplementation if ferritin is <75 ng/mL<75 \text{ ng/mL}.
Soru 10Soru →

A 31-year-old man comes to the clinic accompanied by his husband due to daytime sleep attacks and episodes of sudden muscle weakness. Over the last 5 months, he has been sleeping 9 to 10 hours per night but still struggles to stay awake during his work as a financial analyst. He reports that when he laughs heartily at a joke, his knees buckle and he occasionally drops his briefcase, though he remains fully conscious. Last month, while falling asleep, he saw a terrifying shadowy figure in his room and was unable to move his limbs for approximately a minute. His medical history is notable for a manic episode at age 22, leading to a diagnosis of bipolar I disorder. He was previously taking valproate but discontinued it a year ago due to weight gain. He is currently taking only tranylcypromine, which was prescribed 2 months ago for an acute depressive episode. Vital signs are within normal limits. Physical examination is unremarkable. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 7.2 µU/mL (normal: 0.5-5.0 µU/mL) and a free thyroxine (T4) level of 1.2 ng/dL (normal: 0.9-1.7 ng/dL).

Which of the following is the most appropriate pharmacotherapy for this patient's sleep-related symptoms?

Cevabı ve açıklamayı göster

Cevap: Sodium oxybate

Cevap

Sodium oxybate
Sodium oxybate is an FDA-approved, highly effective treatment for both the excessive daytime sleepiness and cataplexy associated with Narcolepsy Type 1. It acts as a central nervous system depressant (via GABA-B and GHB receptors) to consolidate fragmented nighttime sleep. Crucially, in this complex patient, sodium oxybate does not carry serotonergic activity, meaning it can be safely co-administered with his current monoamine oxidase inhibitor (tranylcypromine) without causing serotonin syndrome. Furthermore, unlike activating antidepressants, it does not carry a high risk of precipitating a manic episode in a patient with bipolar I disorder who is currently off mood stabilizers.

Adım Adım Çözüm

1
Identify the primary diagnosis based on the clinical presentation.
The patient's excessive daytime sleepiness, cataplexy (muscle weakness triggered by laughter), hypnagogic hallucinations, and sleep paralysis are diagnostic of Narcolepsy Type 1.
Recognizing the full tetrad of narcolepsy symptoms differentiates it from other causes of fatigue, such as hypothyroidism or depression.
2
Evaluate the patient's current medication regimen and medical history for potential contraindications.
The patient has Bipolar I disorder not covered by a mood stabilizer, and is currently taking tranylcypromine, a monoamine oxidase inhibitor (MAOI).
Standard off-label cataplexy treatments (SSRIs/SNRIs) pose extreme risks in this specific patient, including manic switch and serotonin syndrome.
3
Select the appropriate therapy that safely addresses the core symptoms.
Sodium oxybate is chosen as the most appropriate pharmacotherapy.
It treats both excessive daytime sleepiness and cataplexy effectively without interacting with the MAOI or precipitating mania.

Anahtar Kavram

Management of Narcolepsy Type 1 in patients with psychiatric comorbidities and complex medication regimens.
Soru 11Soru →

A 58-year-old man presents to the clinic for evaluation of progressive fatigue and poor concentration over the past 6 months. He states that he sleeps 8 hours each night but frequently awakens feeling unrefreshed and with a diffuse morning headache. His wife reports that he snores loudly and occasionally appears to stop breathing for short periods, often waking up with a sudden gasp. He consumes 2 to 3 alcoholic beverages nightly. His medical history includes type 2 diabetes mellitus and hypertension. Current medications are metformin and lisinopril. BMI is 34 kg/m234 \text{ kg/m}^2. Blood pressure is 152/94 mmHg152/94 \text{ mmHg}, pulse is 78/min78 \text{/min}, and respirations are 14/min14 \text{/min}. Cardiopulmonary examination reveals clear lungs bilaterally, regular heart rhythm without murmurs, and no jugular venous distention. Laboratory studies show a normal serum thyroid-stimulating hormone concentration. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Perform overnight polysomnography

Cevap

The correct answer is to perform overnight polysomnography.
This patient presents with a classic clinical picture of Obstructive Sleep Apnea (OSA), characterized by daytime fatigue, unrefreshing sleep, diffuse morning headaches, loud snoring, and witnessed apneic episodes terminating in gasps. His risk factors include obesity (BMI > 30), male sex, advancing age, and evening alcohol use, which relaxes upper airway musculature. The most appropriate next step in management for a patient with high clinical suspicion for OSA is an overnight polysomnography (sleep study). This test definitively diagnoses OSA by measuring the Apnea-Hypopnea Index (AHI) and guides subsequent treatment, such as continuous positive airway pressure (CPAP) therapy or lifestyle modifications.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
Identify classic symptoms of Obstructive Sleep Apnea (OSA), including obesity, loud snoring, witnessed apneas, morning headaches, and unrefreshing sleep.
Recognizing the constellation of symptoms is essential to form the correct primary differential diagnosis.
2
Differentiate the symptoms from other etiologies.
Rule out heart failure (normal cardiopulmonary exam), hypothyroidism (normal TSH), and primary depression (airway symptoms are dominant).
Fatigue and sleep disturbances have a broad differential that must be narrowed using physical exam and basic laboratory findings.
3
Determine the initial diagnostic standard for the suspected condition.
Select polysomnography to formally diagnose and quantify the severity of the suspected OSA.
A sleep study is required to calculate the Apnea-Hypopnea Index (AHI) before initiating treatments like CPAP.

Anahtar Kavram

Diagnosis of Obstructive Sleep Apnea requires polysomnography to confirm the presence and severity of apneic episodes.
Soru 12Soru →

An otherwise healthy 22-year-old college student seeks medical advice because of irrepressible daytime sleepiness that has been present for the last six months. She consistently falls asleep during her morning lectures and on the bus commute, despite maintaining a regular schedule of eight hours of sleep per night. She notes that her nighttime sleep is frequently fragmented. When asked about other symptoms, she describes several alarming episodes where her knees suddenly buckled and she experienced transient facial weakness specifically when laughing at a friend's joke, forcing her to sit down immediately. Additionally, she reports occasionally seeing a frightening, shadowy figure in her room just as she is drifting off to sleep. Her medical history is unremarkable, and she takes no medications or illicit substances. Vital signs and physical examination are within normal limits. Which of the following is most likely to be found during further evaluation of this patient?

Cevabı ve açıklamayı göster

Cevap: Decreased cerebrospinal fluid hypocretin-1 concentration

Cevap

The patient is most likely to have decreased levels of hypocretin-1 (orexin-A) in the cerebrospinal fluid.
The patient's clinical presentation of excessive daytime sleepiness, cataplexy (sudden, transient muscle weakness triggered by strong emotions like laughter), and hypnagogic hallucinations (visual hallucinations occurring at sleep onset) is highly characteristic of narcolepsy type 1. This primary sleep-wake disorder is fundamentally caused by the selective loss of orexin (hypocretin)-producing neurons situated in the lateral hypothalamus. Consequently, a diagnostic lumbar puncture in patients with narcolepsy type 1 classically reveals abnormally low levels of hypocretin-1 in the cerebrospinal fluid.

Adım Adım Çözüm

1
Analyze the core clinical symptoms.
The patient presents with excessive daytime sleepiness for 6 months, cataplexy (muscle weakness specifically with laughter), and hypnagogic hallucinations (seeing figures when falling asleep).
Identifying the cardinal symptoms and their exact triggers is the first step in diagnosing a primary sleep-wake disorder.
2
Synthesize the findings to formulate a diagnosis.
The combination of irrepressible daytime sleepiness, cataplexy, and hypnagogic hallucinations is pathognomonic for narcolepsy type 1.
Grouping the symptoms helps differentiate narcolepsy from other causes of hypersomnia, such as insufficient sleep syndrome or secondary fatigue.
3
Identify the underlying pathophysiology and expected diagnostic findings.
Narcolepsy type 1 is caused by the autoimmune destruction of hypocretin (orexin) neurons in the lateral hypothalamus, leading to definitively decreased hypocretin-1 levels in the cerebrospinal fluid.
The question asks for the most likely finding during further evaluation, requiring knowledge of the specific neurochemical marker for this disease.

Anahtar Kavram

Narcolepsy Type 1 pathophysiology and diagnosis
Soru 13Soru →

A 68-year-old man is brought to the clinic by his husband. For the past 8 months, the patient has experienced episodes of shouting, thrashing, and kicking during sleep, typically occurring in the early morning hours. During a recent episode, he accidentally struck his husband in the face. When awakened from these events, the patient reports vivid, action-packed dreams in which he is defending himself from intruders. He has no history of head trauma, seizures, or psychiatric illness. Current medications include a daily multivitamin. Vital signs are within normal limits, and the physical examination, including a detailed neurologic assessment, reveals no abnormalities.

Arrange the following steps in the most appropriate chronological sequence for the diagnostic evaluation and longitudinal management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Video-polysomnography, 2) Environmental safety precautions, 3) Pharmacotherapy, 4) Longitudinal neurodegenerative monitoring.
The evaluation of suspected REM sleep behavior disorder (RBD) must begin with an overnight video-polysomnography to confirm the diagnosis by demonstrating REM sleep without atonia (RSWA) and ruling out mimics. Following a confirmed diagnosis, immediate environmental safety measures (e.g., removing nightstands, placing the mattress on the floor) form the cornerstone of initial non-pharmacologic management to prevent injury. If these safety measures are insufficient or behaviors are intrinsically highly dangerous, pharmacotherapy with melatonin or clonazepam is added as the next step. Finally, because idiopathic RBD is a recognized prodrome for alpha-synucleinopathies, establishing continuous long-term neurological monitoring is essential.

Adım Adım Çözüm

1
Identify the likely diagnosis based on the clinical presentation.
The patient's vivid dream enactment in the early morning (REM sleep predominant) strongly suggests REM sleep behavior disorder (RBD).
Establishing the preliminary clinical diagnosis dictates the required diagnostic testing.
2
Determine the necessary objective diagnostic test.
Overnight video-polysomnography is required first.
RBD cannot be diagnosed on clinical history alone; it requires objective demonstration of loss of normal REM sleep atonia and the exclusion of other sleep disorders.
3
Sequence the acute management interventions.
Non-pharmacologic safety measures must be implemented before or alongside medications.
Environmental safety is universally recommended and carries no risk, whereas medications like clonazepam have potential adverse effects in older adults.
4
Identify long-term prognostic needs.
Longitudinal neurological monitoring is established.
A significant majority of patients with idiopathic RBD will eventually develop an alpha-synucleinopathy, requiring long-term surveillance.

Anahtar Kavram

REM Sleep Behavior Disorder (RBD) diagnostic and management algorithm
Tahmini Süre:1m 30s
Soru 14Soru →

A 31-year-old woman, gravida 2, para 1, at 28 weeks gestation is evaluated in the outpatient clinic for severe insomnia. Over the past month, she has been unable to fall asleep because of an uncomfortable, aching sensation deep within her calves. She states, "I feel an overwhelming urge to move my legs to make the feeling stop." These symptoms occur exclusively when she lies down to rest at night and improve significantly when she gets out of bed and paces around the house. Her medical history includes generalized anxiety disorder, which has been stable on sertraline for the past two years. Her prenatal course has been uncomplicated, and vital signs are normal. Neurological examination reveals normal muscle strength, tone, and deep tendon reflexes in the lower extremities. Which of the following is the most appropriate initial step in the evaluation or management of this patient's sleep complaint?

Cevabı ve açıklamayı göster

Cevap: Measure serum ferritin concentration

Cevap

The most appropriate initial step is to measure the serum ferritin concentration.
The correct answer is to measure the serum ferritin concentration. This patient's clinical presentation—an irresistible urge to move her legs that worsens at night and during rest, and improves with movement—is diagnostic of Restless Legs Syndrome (RLS). RLS is a sensorimotor sleep-wake disorder that can be primary or secondary. Secondary causes are common and include pregnancy, uremia, diabetes mellitus, and medications (especially SSRIs, SNRIs, and antiemetics). Crucially, depleted iron stores in the central nervous system play a major role in the pathophysiology of RLS. Therefore, measuring a serum ferritin level is the standard initial step in evaluation for all patients with new-onset RLS, even if a complete blood count shows no overt anemia. A ferritin level below 75 ng/mL warrants iron supplementation.

Adım Adım Çözüm

1
Analyze the patient's symptoms based on timing and alleviating factors.
The irresistible urge to move the legs, worsening at rest and at night, and relief with movement indicate a clinical diagnosis of Restless Legs Syndrome (RLS).
Accurate diagnosis of the sleep-wake disorder guides appropriate workup and prevents unnecessary testing.
2
Identify potential secondary causes or exacerbating factors present in the patient's history.
The patient is pregnant and taking an SSRI (sertraline), both of which are strong risk factors for developing or worsening RLS.
Understanding the multifactorial etiology of RLS helps in managing reversible causes.
3
Determine the standard initial diagnostic workup for new-onset RLS.
Evaluate iron stores by measuring a serum ferritin concentration.
Iron deficiency, even without overt anemia, is a primary reversible cause of RLS, and central nervous system iron depletion contributes to the disorder's pathophysiology.

Anahtar Kavram

The diagnosis of Restless Legs Syndrome is primarily clinical. All patients with new-onset symptoms should have their serum ferritin concentration checked, as iron deficiency is a common, reversible cause of the disorder.
Tahmini Süre:1m 15s
Soru 15Soru →

Match each polysomnography (PSG) or Multiple Sleep Latency Test (MSLT) finding to the most appropriate sleep-wake disorder diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Sustained electromyographic (EMG) tone on chin leads during epochs of rapid eye movements and low-voltage, mixed-frequency EEG.
Mean sleep latency of 6 minutes and two sleep-onset REM periods (SOREMPs) across five daytime nap opportunities.
Recurrent episodes of absent airflow lasting >10 seconds without associated thoracic or abdominal respiratory excursions.
Apnea-hypopnea index of 25 events per hour characterized by absent airflow with paradoxical inward rib cage and outward abdominal movements.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Sustained EMG tone during REM matches REM Sleep Behavior Disorder; early REM onset and shortened sleep latency on MSLT matches Narcolepsy; absent airflow without respiratory effort matches Central Sleep Apnea; and absent airflow with paradoxical respiratory effort matches Obstructive Sleep Apnea.
Polysomnography (PSG) and the Multiple Sleep Latency Test (MSLT) provide objective measures to diagnose specific sleep-wake disorders. REM sleep behavior disorder is characterized by a lack of normal muscle atonia during REM sleep, observed as sustained EMG tone. Narcolepsy is objectively diagnosed on MSLT by a sleep latency of 8 minutes or less and 2 or more SOREMPs. Sleep apnea syndromes are differentiated by respiratory effort during apneic events: effort is present in obstructive sleep apnea (causing paradoxical chest and abdominal movements) and absent in central sleep apnea.

Adım Adım Çözüm

1
Analyze the first finding of sustained EMG tone during REM sleep.
This indicates a loss of normal REM sleep muscle atonia.
Loss of REM atonia is the key diagnostic finding for REM sleep behavior disorder, explaining dream enactment behaviors.
2
Analyze the MSLT finding of a 6-minute sleep latency with two SOREMPs.
These findings show objective hypersomnolence and premature entry into REM sleep.
These are the pathognomonic diagnostic criteria for narcolepsy.
3
Analyze the finding of absent airflow without thoracic or abdominal excursions.
This indicates an absence of respiratory drive during the apneic event.
A lack of respiratory effort during apneic episodes defines central sleep apnea.
4
Analyze the finding of absent airflow with paradoxical inward rib cage and outward abdominal movements.
This indicates continued respiratory effort against a closed upper airway.
Respiratory effort against an obstructed airway is the hallmark finding of obstructive sleep apnea.

Anahtar Kavram

Differentiating sleep-wake disorders based on pathognomonic polysomnography and MSLT findings
Soru 16Soru →

An occupational health physician is evaluating a 49-year-old male warehouse manager due to unintended sleep episodes at work over the past 7 months. The patient states, 'No matter how early I go to bed, I wake up with a morning headache and feel exhausted.' His bed partner recently moved to a separate bedroom due to his disruptive, loud snoring and intermittent gasping sounds during the night. Medical history is notable for essential hypertension and bipolar II disorder, which has been stable on lamotrigine for five years. Current medications include lisinopril and lamotrigine. His body mass index is 36 kg/m236 \text{ kg/m}^2. Vital signs are within normal limits. Physical examination reveals a crowded oropharynx and 1+ bilateral pitting edema in the lower extremities. Laboratory studies reveal a normal thyroid-stimulating hormone level of 1.9 \muU/mL1.9 \text{ \mu U/mL} and a normal free T4 level. The patient expresses concern because a previous physician mentioned a 'borderline low thyroid hormone' level years ago. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Order an overnight polysomnography

Cevap

Order an overnight polysomnography
The clinical presentation of excessive daytime sleepiness, nonrestorative sleep, morning headaches, loud snoring, and witnessed gasping in an overweight male strongly suggests obstructive sleep apnea (OSA). A crowded oropharynx and elevated body mass index further increase the pretest probability. The definitive next step for diagnosing OSA is an overnight polysomnography (sleep study), which measures the apnea-hypopnea index (AHI) to confirm the diagnosis and guide subsequent therapy.

Adım Adım Çözüm

1
Identify the classic clinical presentation of the patient's sleep disturbance.
The patient exhibits excessive daytime sleepiness, nonrestorative sleep, morning headaches, loud snoring, and witnessed apneas (gasping).
Recognizing this symptom cluster is essential to suspect Obstructive Sleep Apnea (OSA).
2
Evaluate risk factors and physical examination findings.
The patient has a high body mass index (36 kg/m236 \text{ kg/m}^2) and a crowded oropharynx, which heavily predispose him to upper airway collapse.
Physical attributes confirm the high pretest probability of OSA.
3
Select the most appropriate initial diagnostic investigation.
An in-lab overnight polysomnography is required to measure the apnea-hypopnea index (AHI) and formally diagnose the condition.
Objective confirmation of sleep-disordered breathing is necessary before initiating continuous positive airway pressure (CPAP) or other therapies.

Anahtar Kavram

Diagnosis of Obstructive Sleep Apnea (OSA)
Soru 17Soru →

A 26-year-old woman is evaluated in the sleep clinic for a 1-year history of irresistible daytime sleep attacks. She reports frequently falling asleep during meetings and while driving. Additionally, she experiences vivid, frightening hallucinations just as she is falling asleep, and transient periods of bilateral leg weakness triggered by sudden laughter. She takes no medications and her physical examination is unremarkable. Arrange the following steps in the most appropriate chronological sequence for the diagnostic evaluation and step-wise pharmacological management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Review a two-week sleep diary, 2) Conduct an overnight polysomnography, 3) Perform a Multiple Sleep Latency Test (MSLT), 4) Initiate modafinil, 5) Add venlafaxine.
The evaluation of suspected narcolepsy type 1 begins with a sleep diary to verify that excessive daytime sleepiness is not simply due to chronic sleep deprivation. Next, an overnight polysomnography (PSG) is strictly required to rule out other sleep disorders (e.g., sleep apnea) and to document at least 6 hours of sleep. The following day, a Multiple Sleep Latency Test (MSLT) is performed to objectively confirm narcolepsy by demonstrating a mean sleep latency of less than 8 minutes and at least two sleep-onset REM periods. Therapeutically, the stepwise approach first addresses excessive daytime sleepiness with a wake-promoting agent like modafinil. Once daytime wakefulness is improved, targeted therapy for cataplexy (emotionally triggered muscle weakness) is added using an REM-suppressing medication such as an SNRI (e.g., venlafaxine).

Adım Adım Çözüm

1
Evaluate the initial diagnostic requirement.
A sleep diary is reviewed.
To establish baseline sleep-wake patterns and rule out chronic sleep deprivation or circadian rhythm disorders prior to formal objective testing.
2
Determine the first objective diagnostic study.
Overnight polysomnography is conducted.
To rule out co-occurring sleep disorders such as obstructive sleep apnea and to confirm the patient has slept enough (at least 6 hours) to validate subsequent daytime testing.
3
Determine the confirmatory diagnostic test.
Multiple Sleep Latency Test (MSLT) is performed.
Conducted the day after polysomnography to detect a shortened sleep latency (under 8 minutes) and at least two sleep-onset REM periods (SOREMPs), which confirms narcolepsy.
4
Establish the initial pharmacological intervention.
Modafinil is prescribed.
Wake-promoting agents are the first-line treatment for managing excessive daytime sleepiness, which is generally the most pervasive and debilitating symptom.
5
Address the patient's cataplexy.
Venlafaxine is added to the regimen.
An SNRI strongly suppresses REM sleep and is highly effective at preventing the emotionally triggered sudden loss of muscle tone (cataplexy) seen in narcolepsy type 1.

Anahtar Kavram

Diagnosis and Stepwise Management of Narcolepsy Type 1
Soru 18Soru →

A 5-year-old boy is brought to the pediatric clinic by his parents due to distressing nighttime episodes that have occurred once or twice a week for the past 3 months. Typically, about 90 to 120 minutes after falling asleep, the child abruptly sits up in bed, screams loudly, and breathes heavily. His parents state that he appears terrified, is dripping with sweat, and thrashes his arms defensively. When they attempt to comfort him, he stares blankly, does not recognize them, and violently resists their attempts to console him. The episodes last 5 to 10 minutes, after which he lies down and peacefully sleeps through the rest of the night. In the morning, he has no memory of the events and acts completely normal. His past medical history is unremarkable, and he is meeting all developmental milestones. The parents are exhausted and extremely worried about a potential underlying psychological or neurological problem. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Reassurance and guidance on maintaining a safe sleep environment

Cevap

Reassurance and guidance on maintaining a safe sleep environment
The correct answer focuses on reassurance and safety. The patient's presentation is classic for sleep terrors (pavor nocturnus), a non-REM parasomnia that typically affects children aged 3 to 7 years. These episodes characteristically occur during slow-wave (N3) sleep, which predominates in the first third of the night (e.g., 90 to 120 minutes after sleep onset). During an episode, the child exhibits intense autonomic arousal (tachycardia, diaphoresis, tachypnea), appears inconsolable, and does not recognize parents. Crucially, there is complete amnesia of the event the following morning. Because sleep terrors are benign and self-limiting (usually resolving by adolescence without sequelae), the most appropriate management is parental reassurance and guidance on maintaining a safe sleep environment (e.g., securing doors, clearing the floor, and removing sharp objects) to prevent injury if the child thrashes or sleepwalks. Attempting to forcefully wake the child during an episode is not recommended as it can prolong the event and worsen agitation.

Adım Adım Çözüm

1
Analyze the timing and clinical features of the sleep episodes.
The episodes occur 90-120 minutes after sleep onset, involve autonomic arousal, unresponsiveness to comforting, and complete morning amnesia.
These features reliably distinguish non-REM parasomnias from REM parasomnias (like nightmares) and nocturnal seizures.
2
Establish the most likely diagnosis based on the clinical presentation.
The clinical picture perfectly matches sleep terrors (pavor nocturnus).
Sleep terrors typically occur during slow-wave (N3) sleep in the first third of the night and are highly common in children aged 3-7 years.
3
Determine the first-line management for the diagnosed condition.
The best approach is reassurance and maintaining a safe sleep environment.
Sleep terrors are a benign, self-limiting developmental phenomenon that do not typically require aggressive medical or psychological intervention.

Anahtar Kavram

Sleep terrors are a benign non-REM parasomnia occurring in the first third of the night, characterized by unresponsiveness and morning amnesia, and are best managed with reassurance and environmental safety.
Sleep-Wake Disorders Alıştırma Soruları — USMLE Step 2 CK | Examkin